Efficacy & Safety of Symbicort® TURBUHALER® 160/4.5 µg Twice Daily & Pulmicort® TURBUHALER® 200 µg Twice Daily + Theolong® Tablet 200 mg Twice Daily in Japanese Asthmatic Patients
Clinical trial NCT00252785 · COMPLETED
Trial details
- NCT number
- NCT00252785
- Sponsor
- AstraZeneca
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2005-10-01
- Enrollment
- 340
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.